Nessuna connessione a internet — viene mostrata la versione salvata della pagina.

IQVIA Holdings In…

USUSD
← Allo Screener

IQVIA Holdings Inc (LSE:0JDM) — Biotechnology: Commercial Physical & Biological Resarch. Numero di borse in cui sono quotate le azioni della società: 2. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.

Informazioni sull'Azienda

Sito Web
iqvia.com
Relazioni con gli Investitori
ir.iqvia.com/
Settore
Health Care · Biotechnology: Commercial Physical & Biological Resarch
Sede Centrale
Durham, United States
Gestione
Ari Bousbib
Dipendenti
94 000
Fondata
2016
Quotata dal
29.01.2018 (LSE:0JDM)
Azioni in Circolazione
164.6 Mln al 2026-07-21
Flottante
156.25 Mln
Capitalizzazione di Mercato
44.25 Mld USD
Insider
1.09%
Investitori Istituzionali
103.42%
Settore (SIC)
Services-Commercial Physical & Biological Research
Forma Giuridica
XTIQ
ISIN
US46266C1053
LEI
549300W3R20NM4KQPH86
P/E
47.1
P/B
7.49
Payout Ratio
41.0%
FCF
2.12 Mld USD
Pagamenti / FCF
27%
Debito
15.8 Mld USD
6.6 anni di FCF
Utili, FCF e dividendi pagati — per i 12 mesi fino a 31.03.2026 (l'ultimo rapporto dell'azienda).
NAV
37.27 USD · P/NAV 7.00
Data del Bilancio31.03.2026
Attività29.7 Mld USD
− Passività23.3 Mld USD
= Patrimonio Netto Totale6.35 Mld USD
− Partecipazioni di Minoranza128 Mln USD
= NAV (capitale azionario degli azionisti della società)6.22 Mld USD
− Avviamento16.5 Mld USD
− Attività Immateriali4.80 Mld USD
= NAV Tangibile−15.1 Mld USD
Azioni166 900 000
NAV per Azione37.27 USD
NAV Tangibile per Azione−90.63 USD
Prezzo dell'Azione (0JDM)261.01 USD
P/NAV7.00
Andamento della NAV
Data del BilancioNAVNAV per Azione
31.03.20266.22 Mld USD37.27 USD
31.12.20256.50 Mld USD38.34 USD
30.09.20256.16 Mld USD36.17 USD
30.06.20255.78 Mld USD33.99 USD
31.03.20255.98 Mld USD34.33 USD
31.12.20246.07 Mld USD34.45 USD
30.09.20246.97 Mld USD38.36 USD
30.06.20246.71 Mld USD36.83 USD
Descrizione

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

pubblicità

Borse e Ticker

BorsaTickerValutaPrezzoTipo
US USA StocksIQV principaleUSD279.36 +0.37%azioni ordinarie
LSE London Stock Exchange0JDM IOBUSD261.01 +0.00%azioni ordinarie

Prezzo su 5 anni (candele settimanali)

giorno di rialzo giorno di ribasso data di stacco del dividendo data di pagamentoPassa il mouse / tocca un giorno — prezzi di apertura, chiusura, massimo e minimo

Dividendi

Nessun pagamento di dividendi trovato (controllato 25.10.2026). Probabilmente la società non distribuisce dividendi.

Principali Azionisti

DetentoreQuotaAzioniData del Rapporto
Blackrock Inc.8.84%14.55 Mln2026-06-30
Harris Associates L.P.7.4%12.18 Mln2026-06-30
Vanguard Capital Managem…6.63%10.91 Mln2026-06-30
State Street Corporation4.56%7.51 Mln2026-06-30
Vanguard Portfolio Manag…4.56%7.5 Mln2026-06-30
JPMORGAN CHASE & CO3.73%6.14 Mln2026-06-30
VANGUARD INDEX FUNDS-Van…3.22%5.3 Mln2026-06-30
Artisan Partners Limited…2.88%4.74 Mln2026-06-30
Boston Partners2.71%4.47 Mln2026-06-30
Geode Capital Management…2.71%4.45 Mln2026-06-30
VANGUARD INDEX FUNDS-Van…2.63%4.32 Mln2026-06-30
VANGUARD INDEX FUNDS-Van…2.2%3.62 Mln2026-06-30
Invesco Ltd.1.99%3.28 Mln2026-06-30
HARRIS ASSOCIATES INVEST…1.58%2.61 Mln2026-06-30
HARRIS ASSOCIATES INVEST…1.56%2.57 Mln2026-06-30
iShares Trust-iShares Co…1.35%2.22 Mln2026-08-31
Fidelity Concord Street…1.31%2.16 Mln2026-07-31
SPDR S&P 500 ETF TRUST-S…1.24%2.04 Mln2026-08-31
VANGUARD WINDSOR FUNDS-V…1.07%1.76 Mln2026-07-31
VANGUARD INDEX FUNDS-Van…0.96%1.59 Mln2026-06-30
BOUSBIB ARI B (Chief Exe…≈0.84%1.38 Mln2026-07-29
BRUEHLMAN RONALD E (Chie…≈0.03%55 9962026-02-06
HAAS BERND (Officer)≈0.01%24 4142026-02-06
GRENFELL ALISTAIR (Offic…≈0.01%24 1242026-02-06
SHERBET ERIC M (General…≈0.01%20 9992026-07-29
LEONARD JOHN M (Director…≈0.01%16 9462026-04-23
GOGGINS COLLEEN A (Direc…≈0.01%14 4532026-04-23
STAUB WALTER. RICHARD II…≈0.01%13 3122026-08-03
FEDOCK MICHAEL J. (Offic…≈0.01%9 5952026-02-06
DANHAKL JOHN G (Director…——2026-04-23